BRAIN Biotech AG Presentation: Industrial Biotech Innovations

BRAIN Biotech AG Company Presentation: Key Takeaways

Discover the Exciting World of Biotechnology with BRAIN Biotech AG

With a diverse portfolio and commitment to sustainability, BRAIN Biotech AG is shaping the future of bio-based products and solutions for a healthier, more sustainable world.

Company Presentation by Michael Schneiders

In this company presentation, Michael Schneiders, Investor Relations, introduces you to the core elements of their business, highlighting the company’s focus on:

Mega-Trends

Production Setup

Value Creation and Synergies

UN-Sustainable Development Goals

Revolutionizing the Industry with CRISPR Cas9 Technology

Learn how BRAIN Biotech AG is revolutionising the industry with its CRISPR Cas9 technology, new business pipeline, and guidance for midterm targets.

Explore the Shareholder Structure

Explore the shareholder structure and discover the six compelling reasons to invest in this cutting-edge company.

Chapters

In the center of Mega-Trends
Production Setup
Value Creation and Synergies
UN-Sustainable Development Goals
New Business Pipeline
CRISPR Cas9 Revolution
Guidance and Midterm Targets
Shareholder Structure
Six Reasons to Invest

Resources

Host

Michael Schneiders
IR | BRAIN Biotech AG

T&C:

This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/

Continuing the Journey: More Presentations

BRAIN Biotech AG Financial Results Q1 2023 / 24 | Strategic Financial Outlook with CFO

Germany

Financial Results

BRAIN Biotech AG Financial Results 9M 2022 / 23 | Journey to Sustainability & Prosperity with CFO

Germany

Financial Results

BRAIN Biotech AG Elevator Pitch 2023 | Sustainable Innovation for the Biological Age with CFO

Germany

Elevator Pitch

BRAIN Biotech AG Financial Results H1 2023 Steady Growth Strategy and Future Outlook with CFO 2 - BRAIN Biotech AG Financial Results H1 2022 / 23 | Steady Growth, Strategy, and Future Outlook with CFO -%sitename%

BRAIN Biotech AG Financial Results H1 2022 / 23 | Steady Growth, Strategy, and Future Outlook with CFO

Germany

Financial Results

Revolutionizing the Food Healthcare Industries with CFO 2 - BRAIN Biotech AG Deep Dive 2023 | Revolutionizing the Food & Healthcare Industries with CFO -%sitename%

BRAIN Biotech AG Deep Dive 2023 | Revolutionizing the Food & Healthcare Industries with CFO

Germany

Deep-Dive

BRAIN Biotech AG Financial Results Q1 2023 Strong Start to Revenue and Cash Improved with CFO 1 - BRAIN Biotech AG Financial Results Q1 2022 / 23 | Revenue and Cash Improved with CFO -%sitename%

BRAIN Biotech AG Financial Results Q1 2022 / 23 | Revenue and Cash Improved with CFO

Germany

Financial Results

BRAIN Biotech AG Financial Results FY 2022 Exploring Growth Challenges and Future Prospects with CFO - BRAIN Biotech AG Financial Results FY 2021 / 22 | Exploring Growth, Challenges, and Future Prospects with CFO -%sitename%

BRAIN Biotech AG Financial Results FY 2021 / 22 | Exploring Growth, Challenges, and Future Prospects with CFO

Germany

Financial Results

BRAIN Biotech AG Financial Results 9M 2022 Unveiling the Future with IR 1 - BRAIN Biotech AG Financial Results 9M 2021/ 22 | Unveiling the Future with IR -%sitename%

BRAIN Biotech AG Financial Results 9M 2021/ 22 | Unveiling the Future with IR

Germany

Financial Results

BRAIN Biotech AG ESG | Targets, Opportunities and Key Points with IR

Germany

BRAIN Biotech AG Financial Results H1 2022 Highlights ESG Commitment and Mid Term Targets with IR 1 - BRAIN Biotech AG Financial Results H1 2021 / 22 | Highlights, ESG and Mid-Term Targets with IR -%sitename%

BRAIN Biotech AG Financial Results H1 2021 / 22 | Highlights, ESG and Mid-Term Targets with IR

Germany

Financial Results

BRAIN Biotech AG Financial Results Q1 2022 Unveiling Strategic Deals Cutting Edge Tech Growth Trajectory with IR - BRAIN Biotech AG Financial Results Q1 2021 / 22 | Unveiling Strategic Deals & Growth Trajectory with IR -%sitename%

BRAIN Biotech AG Financial Results Q1 2021 / 22 | Unveiling Strategic Deals & Growth Trajectory with IR

Germany

Financial Results

BRAIN Biotech AG Financial Results FY 2021 Financials Innovations and Sustainability Commitments with IR 1 - BRAIN Biotech AG Financial Results FY 2020 / 21 | Innovations, and Sustainability Commitments with IR -%sitename%

BRAIN Biotech AG Financial Results FY 2020 / 21 | Innovations, and Sustainability Commitments with IR

Germany

Financial Results

Discover Additional Elevator Pitches

Palfinger AG Elevator Pitch | Expanding Horizons in Lifting Solutions with CFO

Austria

Elevator Pitch

LEG Immobilien SE Elevator Pitch | Strategic Insights for 2024 with IR

Germany

Elevator Pitch

eDreams ODIGEO S.A. Elevator Pitch | Game-Changing Subscription Model with CEO

Spain

Elevator Pitch

Berentzen Gruppe AG Elevator Pitch | Resilience and Innovation – Vision 2028 with CEO

Germany

Elevator Pitch

LEG Immobilien SE Elevator Pitch | Germany’s Prime Residential Market with IR

Germany

Elevator Pitch

AIXTRON SE Elevator Pitch | Future in Semiconductor Technology with IR

Germany

Elevator Pitch

Mexedia SpA Elevator Pitch | Future of Tech & Telco with Chairman

France
Italy

Elevator Pitch

SIXT SE Elevator Pitch | Mobility Revolution with CFO

Germany

Elevator Pitch

Hypoport SE Elevator Pitch | Dominating the Digital Shift with CEO

Germany

Elevator Pitch

Warimpex AG Elevator Pitch | Pioneering Flex Office Spaces with CEO

Austria

Elevator Pitch

BRAIN Biotech AG Elevator Pitch 2023 | Sustainable Innovation for the Biological Age with CFO

Germany

Elevator Pitch

ZEAL Network SE Elevator Pitch 2023 | Opportunities in the Lottery Industry with CFO

Germany

Elevator Pitch

BRAIN Biotech AG Company Presentation | Pioneering the Future of Industrial Biotechnology with IR

BRAIN Biotech AG Company Presentation: Key Takeaways

Discover the Exciting World of Biotechnology with BRAIN Biotech AG